Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Melanoma

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    December 2022
  1. SAUD A, Sagineedu SR, Ng HS, Stanslas J, et al
    Melanoma metastasis: What role does melanin play? (Review).
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    July 2022
  2. ZHANG YJ, Xie R, Jiang J, Zhai L, et al
    5AzadC suppresses melanoma progression by inhibiting GAS5 hypermethylation.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    February 2022
  3. KO H, Ahn HJ, Kim YI
    Methylation and mutation of the inhibinalpha gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    November 2021
  4. HAN X, Jia Y, Chen X, Sun C, et al
    lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR4245p/LATS1 axis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    October 2021
  5. CHEN Y, Zhang Z, Luo C, Chen Z, et al
    [Retracted] MicroRNA18b inhibits the growth of malignant melanoma via inhibition of HIF1alphamediated glycolysis.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    September 2021
  6. KODAMA S, Podyma-Inoue KAlpha, Uchihashi T, Kurioka K, et al
    Progression of melanoma is suppressed by targeting all transforming growth factorbeta isoforms with an Fc chimeric receptor.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    August 2021
  7. STACHYRA-STRAWA P, Ciesielka M, Janiszewski M, Grzybowska-Szatkowska L, et al
    The role of immunotherapy and moleculartargeted therapy in the treatment of melanoma (Review).
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    April 2021
  8. URANOWSKA K, Kalic T, Valtsanidis V, Kitzwogerer M, et al
    Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: